Eli Lilly and Company (NYSE:LLY) is one of the 13 best blue-chip stocks to buy, according to analysts. On June 30, RBC ...

While Eli Lilly’s LLY top-line continues to touch new sky highs thanks to its blockbuster GLP-1 medicines — Mounjaro (for ...

Since the city's establishment in the 1820s, Indianapolis has been a magnet for immigrants seeking opportunity and refuge.

BENGALURU: The Health and Family Welfare Department has written to the Drug Controller General of India (DCGI), seeking an ...

The Howard County Board of Education is suing several Big Pharma companies for allegedly inflating insulin prices, affecting ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Procedure was performed on 54-yr-old patient from Jharkhand suffering from advanced osteoarthritis and severe knee ...

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cash flow is valuable, but it’s not everything ...

Just two days after Novo Nordisk launched Wegovy (semaglutide 2.4 mg) in India, Eli Lilly received regulatory approval for the KwikPen® format of its rival therapy Mounjaro (tirzepatide) ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds industry ...

A PIL has claimed that licences for these drugs were issued without adequate data or India-specific trials and studies, ...

Exclusive Global Rights: Neurizon is granted exclusive global rights to Elanco's data package and related intellectual ...